Patent Assignment
Reel/Frame 016662/0582
Change of Name
Recorded: 2005-08-25
Pages: 2
Assignor
MICROLOGIX BIOTECH INC.
Executed: 2004-09-09
Assignee
MIGENIX INC.
3650 WESBROOK MALL, VANCOUVER BRITISH COLUMBIA, V6S 2L2, CANADA
Covered Properties
(22)
Compositions and Methods for Treating Infections Using Analogues of Indolicidin
Patent:
6,180,604 →
Application:
08/915,314 →
Compositions and Methods for Treating Infections Using Cationic Peptides Alone or in Combination with Antibiotics
Efficient Methods for Producing Anti-Microbial Cationic Peptides in Host Cells
Patent:
6,946,261 →
Application:
09/444,281 →
Compositions and Methods for Treating Infections Using Analogues of Indolicidin
Patent:
6,538,106 →
Application:
09/667,486 →
Combinatorial Library Synthesis and Pharmaceutically Active Compunds Produced Thereby
Patent:
6,620,796 →
Application:
09/709,246 →
Derivatives of Laspartomycin and Preparation and Use Thereof
Patent:
6,511,962 →
Application:
09/760,328 →
Water-Soluble Amide Derivatives of Polyene Macrolides and Preparation and Uses Thereof
Derivatives of Laspartomycin and Preparation and Use Thereof
Antimicrobial Sulfonamide Derivatives of Lipopeptide Antibiotics
Extractive Purification of Lipopeptide Antibiotics
Derivatives of Polyene Macrolides and Preparation and Use Thereof
Antimicrobial Cationic Peptides and Formulations Thereof
Antimicrobial and Anti-Inflammatory Peptides
Compositions and Methods for Treating Infections Using Cationic Peptides Alone or in Combination with Antibiotics
Anti-viral 7-deaza L-nucleosides
Application:
10/326,573 →
Publication:
US 2003/0153744
DAB9 Derivatives of Lipopeptide Antibiotics and Methods of Making and Using the Same
Compositions and Methods for Treating Infections Using Analogues of Indolicidin
Methods for producing modified anti-infective peptides
Application:
10/395,896 →
Publication:
US 2003/0219854
Anti-viral 7-deaza D-nucleosides and uses thereof
Application:
10/627,586 →
Publication:
US 2005/0026853
Extractive Purification of Lipopeptide Antibiotics
Antimicrobial Cationic Peptides and Formulations Thereof
Efficient methods for producing antimicrobial cationic peptides in host cells
Application:
11/068,783 →
Publication:
US 2005/0260715
Related Assignments
(14)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 5, 2001
From: BORDERS, DONALD B.; CURRAN, WILLIAM V.; FANTINI, AMEDEO A.; FRANCIS, NOREEN D.
To: INTRABIOTICS PHARMACEUTICALS, INC.
Reel/Frame 012150/0683 →
Assignment of Assignor's Interest
Sep 5, 2001
From: CURRAN, WILLIAM V.; LEESE, RICHARD A.; JAROLMEN, HOWARD; BORDERS, DONALD B.
To: INTRABIOTICS PHARMACEUTICALS, INC.
Reel/Frame 012151/0226 →
Assignment of Assignor's Interest
Sep 6, 2001
From: BORDERS, DONALD B.; FRANCIS, NOREEN D.; FANTINI, AMEDEO A.
To: INTRABIOTICS PHARMACEUTICALS, INC.
Reel/Frame 012157/0438 →
Assignment of Assignor's Interest
Jun 19, 2003
From: GUARNA, MARIA MARTA; CHEN, YUCHEN; CORY, ROBERT; BRINKMAN, JACQUI
To: MICROLOGIX BIOTECH INC.
Reel/Frame 014185/0035 →
Assignment of Assignor's Interest
Nov 20, 2003
From: MEKOUAR, KHALID; DEZIEL, ROBERT
To: MICROLOGIX BIOTECH INC.
Reel/Frame 014712/0690 →
Assignment of Assignor's Interest
Feb 23, 2004
From: KRIEGER, TIMOTHY J.; MCNICOL, PATRICIA J.
To: MICROLOGIX BIOTECH INC.
Reel/Frame 014994/0543 →
Assignment of Assignor's Interest
Nov 2, 2004
From: FRASER, JANET R.; FIDAI, SHAFIQUE; CHEN, YUCHEN; KRIEGER, TIMOTHY J.
To: MICROLOGIX BIOTECH INC.
Reel/Frame 015324/0582 →
Assignment of Assignor's Interest
May 4, 2006
From: MIGENIX INC.
To: COMPUTERSHARE TRUST COMPANY, INC.
Reel/Frame 017823/0581 →
Assignment of Assignor's Interest
Jun 23, 2010
From: MIGENIX INC.
To: BIOWEST THERAPEUTICS INC.
Reel/Frame 024576/0618 →
Change of Name
Aug 27, 2010
From: MIGENIX INC.
To: BIOWEST THERAPEUTICS INC.
Reel/Frame 024892/0492 →
Assignment of Assignor's Interest
Sep 23, 2010
From: BIOWEST THERAPEUTICS INC.
To: BIOSOURCE PHARM, INC.
Reel/Frame 025026/0536 →
Corrective Assignment to Correct the Correct Assignee's Address Previously Recorded on Reel 025026 Frame 0536. Assignor(S) Hereby Confirms the Correct Address of Assignee Biosource Pharm, Inc. Should Be Spring Valley, New York 10977.
Apr 26, 2011
From: BIOWEST THERAPEUTICS INC.
To: BIOSOURCE PHARM, INC.
Reel/Frame 026181/0251 →
Assignment of Assignor's Interest
May 6, 2014
From: MIGENIX INC.
To: BIOWEST THERAPEUTICS INC.
Reel/Frame 032829/0078 →
Change of Name
May 6, 2014
From: BIOWEST THERAPEUTICS INC.
To: CARRUS CAPITAL CORPORATION
Reel/Frame 032829/0089 →